American Cyanamid Company

Bernard Beer

Jay Donald Albright

Andrew S Tomcufcik

John P Dusza

Joseph William Epstein

N-methyl-N-(3-&lcub;3-&lsqb;2-thienylcarbonyl&rsqb;-pyrazol-&lsqb;1,5-&agr;&rsqb;-pyrimidin-7-yl&rcub;phenyl)acetamide, and use of the same as a sedative-hypnotic, anxiolytic, anticonvulsant, and skeletal muscle relaxant agent. Compositions containing N-methyl-N-(3-&lcub;3-&lsqb;2-thienylcarbonyl&rsqb;-pyrazol-&lsqb;1,5-&agr;&rsqb;-pyrimidin-7-yl&rcub;phenyl)acetamide, as well as pharmaceutically acceptable salts thereof, are also disclosed.

N-methyl-N-(3-&lcub;3-&lsqb;2-thienylcarbonyl&rsqb;-pyrazol-&lsqb;1, 5-&agr;&rsqb;-pyrimidin-7-yl&rcub;phenyl)acetamide and compositions and methods related thereto

The invention is a method of treatment for the relief of an addictive, compulsive disorder which comprises the administration to a human or animal suffering from such a disorder an effective amount of the compound of the formula:

Growing community of inventors

Cliffside Park, NJ, United States of America

Bernard Beer